{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:56:07Z","timestamp":1778626567672,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.euroneuro.2004.11.005","type":"journal-article","created":{"date-parts":[[2005,1,27]],"date-time":"2005-01-27T12:53:17Z","timestamp":1106830397000},"page":"311-317","source":"Crossref","is-referenced-by-count":74,"title":["Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain"],"prefix":"10.1016","volume":"15","author":[{"given":"Francesco","family":"Angelucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Aloe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Iannitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne H.M.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander A.","family":"Math\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2004.11.005_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","article-title":"Serotonin model of schizophrenia: emerging role of glutamate mechanisms","volume":"31","author":"Aghajanian","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00008877-200006000-00007","article-title":"Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders","volume":"11","author":"Aloe","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0166-2236(98)01273-9","article-title":"Neurotrophin trafficking by anterograde transport","volume":"21","author":"Altar","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1461145700001759","article-title":"Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions","volume":"3","author":"Angelucci","year":"2000","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration","volume":"60","author":"Angelucci","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6123(03)46011-1","article-title":"Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia","volume":"146","author":"Angelucci","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02245617","article-title":"Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial","volume":"124","author":"Beasley","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib8","first-page":"699","article-title":"Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro","volume":"262","author":"Bowden","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02245608","article-title":"Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats","volume":"124","author":"Bymaster","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/S0007125000293653","article-title":"Olanzapine: a basic science update","volume":"37","author":"Bymaster","year":"1999","journal-title":"Br. J. Psychiatr., Suppl."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0169-328X(97)00213-1","article-title":"NGF content and expression in the rat pituitary gland and regulation by thyroid hormone","volume":"51","author":"Calz\u00e0","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(02)03215-8","article-title":"Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration","volume":"954","author":"Chlan-Fourney","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0031-9384(00)00310-3","article-title":"Prenatal exposure to methylazoxymethanol acetate in the rat alters neurotrophin levels and behavior: considerations for neurodevelopmental diseases","volume":"71","author":"Fiore","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jnr.10609","article-title":"Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-d-aspartate receptor activity","volume":"72","author":"Fumagalli","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-4159.1966.tb09873.x","article-title":"Regional studies of catecholamines in the rat brain: I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain","volume":"13","author":"Glowinski","year":"1966","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0278-5846(03)00112-X","article-title":"Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains","volume":"27","author":"Iritani","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.155.7.921","article-title":"5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation","volume":"155","author":"Kapur","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3940(86)90186-2","article-title":"Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNANGF content","volume":"66","author":"Korsching","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130050551","article-title":"Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum","volume":"136","author":"Li","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-4547(19990401)56:1<72::AID-JNR9>3.0.CO;2-0","article-title":"Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor","volume":"56","author":"Li","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1460-9568.2001.01633.x","article-title":"BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs","volume":"14","author":"Lipska","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib22","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.93.9.4240","article-title":"Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism","volume":"93","author":"Missale","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1192\/S0007125000293665","article-title":"Olanzapine: preclinical pharmacology and recent findings","volume":"37","author":"Moore","year":"1999","journal-title":"Br. J. Psychiatr., Suppl."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib36","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2003.10.079","article-title":"Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol","volume":"356","author":"Parikh","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1210\/en.135.4.1689","article-title":"Nerve growth factor and its receptor in the anterior pituitary","volume":"135","author":"Patterson","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib26","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0920-9964(98)00158-3","article-title":"Prolactin and antipsychotic medications: mechanism of action","volume":"35","author":"Petty","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib27","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/S0024-3205(00)00899-7","article-title":"Studies on the involvement of histamine in the hypothalamic\u2013pituitary\u2013adrenal axis activation induced by nerve growth factor","volume":"67","author":"Scaccianoce","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/MN:24:1-3:183","article-title":"Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions","volume":"24","author":"Skaper","year":"2001","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0029-7844(98)00066-0","article-title":"Pattern of development of hyperprolactinemia after initiation of haloperidol therapy","volume":"91","author":"Spitzer","year":"1998","journal-title":"Obst. Gynaecol."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.mp.4000718","article-title":"Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients","volume":"5","author":"Takahashi","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2004.11.005_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s007020050040","article-title":"Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article","volume":"105","author":"Thome","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/ajp.154.4.457","article-title":"Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial","volume":"154","author":"Tollefson","year":"1997","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib33","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","article-title":"Atypical neuroleptics stimulate neurogenesis in adult rat brain","volume":"69","author":"Wakade","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2004.11.005_bib35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.mp.4001308","article-title":"Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia","volume":"8","author":"Weickert","year":"2003","journal-title":"Mol. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04001993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04001993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T02:52:45Z","timestamp":1548816765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X04001993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0924977X04001993"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2004.11.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}